Prenuvo and UT Dallas researchers found links between sleep efficiency, visceral fat and brain volume, with long sleepers ...

Mission Therapeutics has begun a 36-patient Phase 1b study of MTX325, a drug aimed at clearing out damaged mitochondria in ...

Swiss fertility heavyweight bets on stem-cell-derived egg maturation – and on ovarian biology as a market worth owning.

After 12 weeks, members of Omada’s GLP-1 Care Track had lost more weight and shifted their body makeup more than people on usual care. A bathroom scale gives you one number and keeps everything else ...

Arrowhead says its RNAi drug crossed the blood-brain barrier in healthy volunteers and sharply lowered tau, a protein tied to Alzheimer’s.

Berlin keynote details Eos SENOLYTIX's pre-clinical results with mitochondrial-targeted geropeptide on healthspan and lifespan.

The Boston company says the deal more than doubles its patient reach and opens a path to brain-based sleep testing in primary care from 2027.

United Therapeutics will test treprostinil SMI in about 40 patients with pulmonary hypertension linked to COPD.

Fitnescity Health opens its 1,000-plus imaging locations to digital health platforms through one API, with Superpower on board. Fitnescity Health says it now has more than 1,000 places across the US ...

A Biograph study using AI on routine heart CT scans found inflammation that cholesterol tests and risk calculators could not ...

Inside XPRIZE Healthspan’s $101m race: how teams are judged, why measurement matters, and what the field gains beyond a single winner. When a prize carries a $101 million price tag, you expect the ...